Demand for drugs, including weight-loss injections, is sending people to dangerous places to get their medicine. But spotting ...

Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...

After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...

Yesterday, we reported that Novo Nordisk (NYSE: NVO) stock crashed over 20% in premarket trading yesterday. The main culprit is the reduced sales forecast for the company’s flagship obesity drug ...

Discover the rise of "Ozempic face" linked to weight loss drugs like semaglutide, its cosmetic effects, and treatments like ...

CEO-to-be Maziar Mike Doustdar will need to stem the company’s tumbling share price as market pressures intensify.

Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...

A Lilly study showed Mounjaro resulted in a lower risk of heart attacks and strokes in patients with diabetes compared with ...

Novo Nordisk said it expects weaker sales growth of its popular weight-loss drug Wegovy due to competition from copycat drugs ...

While Ozempic is effective at treating type 2 diabetes and supporting weight loss, it can also come with side effects.

We can't have it both ways. If we want more cutting-edge drugs, we have to protect the property rights that make them ...

Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...